Risultati della ricerca - Nicholas J. Slipek
- Mostra 1 - 6 risultati su 6
-
1
-
2
Highly efficient multiplex human T cell engineering without double-strand breaks using Cas9 base editors di Beau R. Webber, Cara-Lin Lonetree, Mitchell G. Kluesner, Matthew J. Johnson, Emily J. Pomeroy, Miechaleen D. Diers, Walker S. Lahr, Garrett M. Draper, Nicholas J. Slipek, Branden A. Smeester, Klaus N. Lovendahl, Amber McElroy, Wendy R. Gordon, Mark J. Osborn, Branden S. Moriarity
Pubblicazione 2019Artigo -
3
CRISPR-Cas9 cytidine and adenosine base editing of splice-sites mediates highly-efficient disruption of proteins in primary and immortalized cells di Mitchell G. Kluesner, Walker S. Lahr, Cara-lin Lonetree, Branden A. Smeester, Xiaohong Qiu, Nicholas J. Slipek, Patricia Claudio-Vázquez, Samuel P. Pitzen, Emily J. Pomeroy, Madison J. Vignes, Samantha C. Lee, Samuel P. Bingea, Aneesha A. Andrew, Beau R. Webber, Branden S. Moriarity
Pubblicazione 2021Artigo -
4
Precision enhancement of CAR-NK cells through non-viral engineering and highly multiplexed base editing di Minjing Wang, Joshua Krueger, Alexandria Gilkey, Erin M. Stelljes, Mitchell G. Kluesner, Emily J. Pomeroy, Joseph G. Skeate, Nicholas J. Slipek, Walker S. Lahr, Patricia Claudio-Vázquez, Yueting Zhao, Jason Bell, Kendell Clement, Ella J. Eaton, Kanut Laoharawee, Jae‐Woong Chang, Beau R. Webber, Branden S. Moriarity
Pubblicazione 2025Artigo -
5
Evolution of the clinical-stage hyperactive TcBuster transposase as a platform for robust non-viral production of adoptive cellular therapies di Joseph G. Skeate, Emily J. Pomeroy, Nicholas J. Slipek, Bryan J. Jones, Bryce Wick, Jae‐Woong Chang, Walker S. Lahr, Erin M. Stelljes, Xiaobai Patrinostro, Blake Barnes, Trevor Zarecki, Joshua Krueger, Jacob Bridge, Gabrielle M. Robbins, Madeline D. McCormick, John R. Leerar, Kari T. Wenzel, Kathlyn Hornberger, Kirsti L. Walker, G. Dalton Smedley, David A. Largaespada, Neil Otto, Beau R. Webber, Branden S. Moriarity
Pubblicazione 2024Artigo -
6
Internal checkpoint regulates T cell neoantigen reactivity and susceptibility to PD1 blockade di Douglas C. Palmer, Beau R. Webber, Yogin Patel, Matthew J. Johnson, Christine M. Kariya, Walker S. Lahr, Maria R. Parkhurst, Jared J. Gartner, Todd D. Prickett, Frank J. Lowery, Rigel J. Kishton, Devikala Gurusamy, Zulmarie Franco, Suman K. Vodnala, Miechaleen D. Diers, Natalie K. Wolf, Nicholas J. Slipek, David H. McKenna, Darin Sumstad, Lydia Viney, Tom Henley, Tilmann Bürckstümmer, O. K. Baker, Ying Hu, Chunhua Yan, Daoud Meerzaman, Kartik Padhan, Winnie Lo, Parisa Malekzadeh, Li Jia, Drew C. Deniger, Shashank J. Patel, Paul F. Robbins, R. Scott McIvor, Modassir Choudhry, Steven A. Rosenberg, Branden S. Moriarity, Nicholas P. Restifo
Pubblicazione 2022Artigo
Strumenti per la ricerca:
Soggetti correlati
Biology
Gene
Genetics
CRISPR
Computational biology
Genome
Genome editing
Immunology
Cas9
Cell biology
Gene expression
Immune system
Immunotherapy
Major histocompatibility complex
Molecular biology
Multiplex
Adoptive cell transfer
Antigen
Biochemistry
Bioinformatics
CD19
CISH
Cancer immunotherapy
Cancer research
Chimeric antigen receptor
Cytidine
DNA
Dicer
Effector
Ensembl